These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27150947)

  • 1. Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects.
    van Riet-Nales DA; Hussain N; Sundberg KA; Eggenschwyler D; Ferris C; Robert JL; Cerreta F
    Int J Pharm; 2016 Oct; 512(2):343-351. PubMed ID: 27150947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population.
    van Riet-Nales DA; Sundberg K; de Boer A; Hirschlérova B
    Br J Clin Pharmacol; 2020 Oct; 86(10):2008-2013. PubMed ID: 32830323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An industrial perspective on the design and development of medicines for older patients.
    Page S; Coupe A; Barrett A
    Int J Pharm; 2016 Oct; 512(2):352-354. PubMed ID: 27001530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population.
    van Riet-Nales DA; van den Bemt B; van Bodegom D; Cerreta F; Dooley B; Eggenschwyler D; Hirschlérova B; Jansen PAF; Karapinar-Çarkit F; Moran A; Span J; Stegemann S; Sundberg K
    Br J Clin Pharmacol; 2022 Feb; 88(4):1500-1514. PubMed ID: 35141926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?
    Doua JY; Van Geertruyden JP
    Trop Med Int Health; 2014 Jan; 19(1):23-36. PubMed ID: 24134396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards more reliable automated multi-dose dispensing: retrospective follow-up study on medication dose errors and product defects.
    Palttala I; Heinämäki J; Honkanen O; Suominen R; Antikainen O; Hirvonen J; Yliruusi J
    Drug Dev Ind Pharm; 2013 Mar; 39(3):489-98. PubMed ID: 22458299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal products for geriatric patients in Germany : Current status of regulatory requirements and clinical reality.
    Gempel-Drey G; Drey M
    Z Gerontol Geriatr; 2020 Jul; 53(4):327-333. PubMed ID: 31041579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(34):9948-9. PubMed ID: 22379685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public engagement workshop: how to improve medicines for older people?
    Orlu-Gul M; Raimi-Abraham B; Jamieson E; Wei L; Murray M; Stawarz K; Stegemann S; Tuleu C; Smith FJ
    Int J Pharm; 2014 Jan; 459(1-2):65-9. PubMed ID: 24291080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
    Beers E; Egberts TC; Leufkens HG; Jansen PA
    Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Regulatory Guidelines into Protein Drug Product Development.
    Wang W
    PDA J Pharm Sci Technol; 2016; 70(1):2-11. PubMed ID: 26889052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scientific advice by the national and European approval authorities concerning advanced therapy medicinal products].
    Jost N; Schüssler-Lenz M; Ziegele B; Reinhardt J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1207-14. PubMed ID: 26369763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.
    Hao Y
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):407-20. PubMed ID: 20715918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery: lessons from evolution.
    Warren J
    Br J Clin Pharmacol; 2011 Apr; 71(4):497-503. PubMed ID: 21395642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.
    Zeitoun JD; Lefèvre JH; Downing NS; Bergeron H; Ross JS
    Br J Clin Pharmacol; 2015 Oct; 80(4):716-26. PubMed ID: 25808713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.